Continuing Enhanced National Surveillance for Prion Diseases in the United States

The Centers for Disease Control and Prevention (CDC) is announcing the availability of FY 2027 funds for a cooperative agreement to continue enhanced national surveillance for human prion diseases in the United States. The purpose is to continue an active surveillance program to help confirm suspected and clinically diagnosed cases of human prion disease and to monitor the occurrence of potentially emerging human prion diseases in the United States. The key aspects of this opportunity include: • Continuing enhanced national surveillance for human prion diseases • Confirming suspected and clinically diagnosed cases of human prion disease • Monitoring the occurrence of potentially emerging human prion diseases in the United States • Funding a specialized center to conduct state-of-the-art diagnostic techniques • Collaborating with CDC experts to provide guidance and epidemiological knowledge